Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

Cambrex fined for safety violations

13-Oct-2008

Related topics: Contract Manufacturing, Analytical testing, QC, Bulk ingredients, Contract sales & marketing, Data management, Drug delivery, formulation, Fill & finish, packaging, Phase I-II, Phase III-IV, Preclinical, Regulatory affairs, Supply chain, logistics, Validation services

After months of deliberations, a court in Iowa has opted to fine contract manufacturing company Cambrex $6,000 for safety violations after an explosion at its facility in Charles City.

Six employees were injured in the blast last October, which occurred in the plant's drying department. One worker was seriously burned and five others were treated for smoke inhalation.

In February, the Iowa Occupational Safety and Health Bureau determined there was insufficient training of employees and inadequate notification and documentation of possible hazards at the plant.

Follow us on

Key Industry Events

Partnerships in Clinical Trials

Orlando, FL 32821 / Conference

Read more

Procurecon Pharma 2012

Zurich-Glattpark, 8152 / Conference and exhibition

Read more

Access our events listing